PIONEER : A Pilot Study of Prone Position Neoadjuvant Breast Radiotherapy to Reduce Skin Toxicity

Female<br/>OnlyGender Female

RecruitingStatus Recruiting


UnknownPhase Unknown

18+Age Over 18

Breast<br/>CancersCancer LocationBreast

Radiotherapy | BreastBreast

Trial Overview Read MoreRead more

This trial is trying to determine the best way of delivering radiation therapy to the breast tissue of people diagnosed with invasive, Grade 1, 2 or 3 breast cancer, before surgery.

This trial is treating patients with breast cancer.

This is a radiotherapy trial.

You may be able to join this trial if:

  • You have had a certain type of treatment or surgical procedure.

You may be excluded from this trial if:

  • You have a certain disease or psychological condition.
  • You have had certain treatments, surgical procedures or drugs.

Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.

Clinical Summary Read MoreRead more

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

Scientific Title

A Pilot Study of Prone Position Neoadjuvant Breast Radiotherapy to Reduce Skin Toxicity

Other Non-Commercial Sponsor

Victorian Comprehensive Cancer Centre & Peter MacCallum Cancer Centre


The duration of this trial is expected to be 3 months for each participant. Radiotherapy treatment will commence at least 4-weeks after completion of standard chemotherapy and will be delivered 5-days a week, over 5-weeks. Approximately 4-8 weeks following successful completion of radiotherapy, the participant will have a surgery to remove the breast and immediate breast reconstruction.

Recruiting Hospitals Read MoreRead more

Peter MacCallum Cancer Centre
Ms Lisa Selbie
(03) 8559 7388

Trial Overview: General information about a clinical trial. This section provides an overview of who might be able to join this trial and what type of treatment is involved.